Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$6.8 - $14.23 $3,563 - $7,456
524 Added 56.89%
1,445 $11,000
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $12,359 - $21,532
921 New
921 $13,000
Q2 2019

Aug 14, 2019

SELL
$17.38 - $26.88 $3,945 - $6,101
-227 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $2,088 - $4,814
227 New
227 $4,000
Q3 2018

Nov 14, 2018

SELL
$8.1 - $13.6 $48,340 - $81,164
-5,968 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$11.2 - $15.0 $66,841 - $89,520
5,968 New
5,968 $68,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $282M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.